{"id":14831,"date":"2023-04-12T06:00:23","date_gmt":"2023-04-12T04:00:23","guid":{"rendered":"https:\/\/thesmartcityjournal.cibeles.net\/sin-categorizar\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson\/"},"modified":"2023-04-11T18:55:21","modified_gmt":"2023-04-11T16:55:21","slug":"la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson","status":"publish","type":"post","link":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson","title":{"rendered":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson"},"content":{"rendered":"<p class=\"lead\">Un informe sobre tendencias globales de I+D subraya que las enfermedades neurol\u00f3gicas acaparan ya el 11% de la investigaci\u00f3n biom\u00e9dica<\/p>\n<p>El Parkinson es, tras el&nbsp;<a href=\"https:\/\/www.farmaindustria.es\/web\/otra-noticia\/investigacion-en-alzheimer-una-historia-de-constancia-compromiso-y-esperanza\/\" target=\"_blank\" rel=\"noopener\">Alzheimer<\/a>, la enfermedad neurol\u00f3gica que acapara m\u00e1s investigaci\u00f3n biom\u00e9dica a nivel global, seg\u00fan el \u00faltimo informe de&nbsp;<em><a href=\"https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/institute-reports\/global-trends-in-r-and-d-2023\/iqvia-institute-global-trends-in-rd-2023-forweb.pdf\" target=\"_blank\" rel=\"noopener\">Tendencias globales en I+D<\/a><\/em>&nbsp;publicado por la consultora Iqvia en febrero de 2023.<\/p>\n<p>En concreto y con datos de 2022, hay&nbsp;96 productos bajo investigaci\u00f3n&nbsp;con el fin de tratar esta patolog\u00eda cr\u00f3nica y progresiva, que afecta a m\u00e1s de siete millones de personas en todo el mundo y que el&nbsp;11 de abril celebra su D\u00eda Mundial.<\/p>\n<p>El Parkinson se caracteriza por la degeneraci\u00f3n de las neuronas en la sustancia negra del cerebro, cuya consecuencia fundamental es la alteraci\u00f3n del control del movimiento. Sin embargo, la afectaci\u00f3n no es \u00fanicamente motora, existen otros s\u00edntomas que van desde la depresi\u00f3n a los trastornos cognitivos, el dolor o problemas de degluci\u00f3n, seg\u00fan los datos de la&nbsp;<a href=\"https:\/\/www.sen.es\/\" target=\"_blank\" rel=\"noopener\">Sociedad Espa\u00f1ola de Neurolog\u00eda<\/a>&nbsp;(SEN).<\/p>\n<p>En Espa\u00f1a se estima que son unas&nbsp;150.000 las personas afectadas de Parkinson, aunque hasta un tercio de los nuevos casos est\u00e1 sin diagnosticar. Son datos de la SEN, que advierte de que el aumento de la esperanza de vida hace prever que la incidencia se triplique en los pr\u00f3ximos 30 a\u00f1os.<\/p>\n<p>La investigaci\u00f3n biom\u00e9dica ha puesto el foco en esta patolog\u00eda, que junto al resto de enfermedades neurol\u00f3gicas concentran el&nbsp;11% de los esfuerzos innovadores. En total, son 699 los productos bajo investigaci\u00f3n en el \u00e1rea neurol\u00f3gica, seg\u00fan los datos del informe de Iqvia. La depresi\u00f3n, la esclerosis m\u00faltiple, la esclerosis lateral amiotr\u00f3fica o la esquizofrenia son otras de las enfermedades que acumulan m\u00e1s ensayos en esta \u00e1rea.<\/p>\n<p>En Espa\u00f1a, desde 2018 los datos del&nbsp;<a href=\"https:\/\/reec.aemps.es\/reec\/public\/list.html\" target=\"_blank\" rel=\"noopener\">Registro Espa\u00f1ol de Estudios Cl\u00ednicos<\/a>&nbsp;(REEC) recogen 45 ensayos enfocados a tratar el Parkinson, una enfermedad de la que a\u00fan no se conoce la causa, aunque se cree que puede ser una combinaci\u00f3n de factores gen\u00e9ticos, derivados del envejecimiento o incluso ambientales.<\/p>\n<p>Estos ensayos cl\u00ednicos son fundamentales para muchos pacientes, ya que gracias a ellos pueden acceder a medicamentos innovadores de forma temprana y mejorar su calidad de vida.<\/p>\n<p>La SEN recuerda la importancia de un diagn\u00f3stico temprano, que permite iniciar el tratamiento de esta enfermedad en las primeras fases y por tanto ayuda a mejorar la calidad de vida de los pacientes, prevenir complicaciones y minimizar la discapacidad a largo plazo.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un informe sobre tendencias globales de I+D subraya que las enfermedades neurol\u00f3gicas acaparan ya el 11% de la investigaci\u00f3n biom\u00e9dica El Parkinson es, tras el&nbsp;Alzheimer, la enfermedad neurol\u00f3gica que acapara m\u00e1s investigaci\u00f3n biom\u00e9dica a nivel global, seg\u00fan el \u00faltimo informe de&nbsp;Tendencias globales en I+D&nbsp;publicado por la consultora Iqvia en febrero de 2023. En concreto y\u2026<\/p>\n","protected":false},"author":2,"featured_media":14830,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_scj_primary_category_id":87,"_scj_featured":false,"_scj_featured_from":"","_scj_featured_until":"","_scj_featured_order":0,"_scj_visibility_class":"current","_scj_layout_family":"standard","_scj_article_style":"","_scj_display_overrides":[],"_scj_intro_image_id":14830,"_scj_intro_alt":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson","_scj_intro_caption":"","_scj_intro_class":"","_scj_intro_float":"","_scj_full_image_id":14830,"_scj_full_alt":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson","_scj_full_caption":"","_scj_full_class":"","_scj_full_float":"","_scj_media_type":"","_scj_media_provider":"","_scj_media_external_id":"","_scj_media_url":"","_scj_media_poster_id":0,"_scj_media_width":0,"_scj_media_height":0,"_scj_media_aspect_ratio":"","_scj_media_description":"","_scj_gallery_items":[],"_scj_related_post_ids":[],"_scj_additional_authors":[],"scj_layout_family":"standard","scj_media_provider":"","scj_media_url":"","scj_full_caption":"","footnotes":""},"categories":[87],"tags":[],"class_list":["post-14831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-smart-health"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson - thesmartcityjournal.com<\/title>\n<meta name=\"description\" content=\"El Parkinson es, tras el\u00a0Alzheimer, la enfermedad neurol\u00f3gica que acapara m\u00e1s investigaci\u00f3n biom\u00e9dica a nivel global, seg\u00fan el \u00faltimo informe de\u00a0Tendencias globales en I+D\u00a0publicado por la consultora Iqvia en febrero de 2023.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson - thesmartcityjournal.com\" \/>\n<meta property=\"og:description\" content=\"El Parkinson es, tras el\u00a0Alzheimer, la enfermedad neurol\u00f3gica que acapara m\u00e1s investigaci\u00f3n biom\u00e9dica a nivel global, seg\u00fan el \u00faltimo informe de\u00a0Tendencias globales en I+D\u00a0publicado por la consultora Iqvia en febrero de 2023.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson\" \/>\n<meta property=\"og:site_name\" content=\"thesmartcityjournal.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thesmartcityjournal\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T04:00:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2023\/04\/tratamientos_Parkinson.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n de The Smart City Journal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartCityJour_\" \/>\n<meta name=\"twitter:site\" content=\"@SmartCityJour_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n de The Smart City Journal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson\"},\"author\":{\"@type\":\"Organization\",\"name\":\"Redacci\u00f3n de The Smart City Journal\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/author\\\/smart-city\"},\"headline\":\"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson\",\"datePublished\":\"2023-04-12T04:00:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson\"},\"wordCount\":461,\"publisher\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/tratamientos_Parkinson.jpg\",\"articleSection\":[\"Smart Health\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson\",\"name\":\"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson - thesmartcityjournal.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/tratamientos_Parkinson.jpg\",\"datePublished\":\"2023-04-12T04:00:23+00:00\",\"description\":\"El Parkinson es, tras el\u00a0Alzheimer, la enfermedad neurol\u00f3gica que acapara m\u00e1s investigaci\u00f3n biom\u00e9dica a nivel global, seg\u00fan el \u00faltimo informe de\u00a0Tendencias globales en I+D\u00a0publicado por la consultora Iqvia en febrero de 2023.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#primaryimage\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/tratamientos_Parkinson.jpg\",\"contentUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/tratamientos_Parkinson.jpg\",\"width\":1280,\"height\":800,\"caption\":\"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/smart-health\\\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/\",\"name\":\"thesmartcityjournal.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#organization\",\"name\":\"thesmartcityjournal.com\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo-smart-city-journal-1.png\",\"contentUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo-smart-city-journal-1.png\",\"width\":346,\"height\":91,\"caption\":\"thesmartcityjournal.com\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/thesmartcityjournal\",\"https:\\\/\\\/x.com\\\/SmartCityJour_\",\"https:\\\/\\\/www.instagram.com\\\/thesmartcityjournal_\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@thesmartcityjournal\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/the-smart-city-journal\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCIPTMzK206pVFxMNjO7SSxw\"]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#\\\/schema\\\/person\\\/39c9da1aeac1b5c2d179ef9e4e293cf4\",\"name\":\"Redacci\u00f3n de The Smart City Journal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3n de The Smart City Journal\"},\"description\":\"Equipo de redacci\u00f3n de The Smart City Journal.\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/author\\\/smart-city\"},{\"@type\":[\"Organization\",\"NewsMediaOrganization\"],\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es#organization\"},{\"@type\":\"SiteNavigationElement\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es#site-navigation\",\"cssSelector\":[\".cib-main-menu\"]},{\"@type\":\"WPHeader\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es#header\",\"cssSelector\":[\".cib-header\"]},{\"@type\":\"WPFooter\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es#footer\",\"cssSelector\":[\".cib-footer\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson - thesmartcityjournal.com","description":"El Parkinson es, tras el\u00a0Alzheimer, la enfermedad neurol\u00f3gica que acapara m\u00e1s investigaci\u00f3n biom\u00e9dica a nivel global, seg\u00fan el \u00faltimo informe de\u00a0Tendencias globales en I+D\u00a0publicado por la consultora Iqvia en febrero de 2023.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson","og_locale":"es_ES","og_type":"article","og_title":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson - thesmartcityjournal.com","og_description":"El Parkinson es, tras el\u00a0Alzheimer, la enfermedad neurol\u00f3gica que acapara m\u00e1s investigaci\u00f3n biom\u00e9dica a nivel global, seg\u00fan el \u00faltimo informe de\u00a0Tendencias globales en I+D\u00a0publicado por la consultora Iqvia en febrero de 2023.","og_url":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson","og_site_name":"thesmartcityjournal.com","article_publisher":"https:\/\/www.facebook.com\/thesmartcityjournal","article_published_time":"2023-04-12T04:00:23+00:00","og_image":[{"width":1280,"height":800,"url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2023\/04\/tratamientos_Parkinson.jpg","type":"image\/jpeg"}],"author":"Redacci\u00f3n de The Smart City Journal","twitter_card":"summary_large_image","twitter_creator":"@SmartCityJour_","twitter_site":"@SmartCityJour_","twitter_misc":{"Escrito por":"Redacci\u00f3n de The Smart City Journal","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#article","isPartOf":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson"},"author":{"@type":"Organization","name":"Redacci\u00f3n de The Smart City Journal","url":"https:\/\/www.thesmartcityjournal.com\/es\/author\/smart-city"},"headline":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson","datePublished":"2023-04-12T04:00:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson"},"wordCount":461,"publisher":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/#organization"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#primaryimage"},"thumbnailUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2023\/04\/tratamientos_Parkinson.jpg","articleSection":["Smart Health"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson","url":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson","name":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson - thesmartcityjournal.com","isPartOf":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#primaryimage"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#primaryimage"},"thumbnailUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2023\/04\/tratamientos_Parkinson.jpg","datePublished":"2023-04-12T04:00:23+00:00","description":"El Parkinson es, tras el\u00a0Alzheimer, la enfermedad neurol\u00f3gica que acapara m\u00e1s investigaci\u00f3n biom\u00e9dica a nivel global, seg\u00fan el \u00faltimo informe de\u00a0Tendencias globales en I+D\u00a0publicado por la consultora Iqvia en febrero de 2023.","breadcrumb":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#primaryimage","url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2023\/04\/tratamientos_Parkinson.jpg","contentUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2023\/04\/tratamientos_Parkinson.jpg","width":1280,"height":800,"caption":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson"},{"@type":"BreadcrumbList","@id":"https:\/\/www.thesmartcityjournal.com\/es\/smart-health\/la-industria-farmaceutica-investiga-casi-un-centenar-de-nuevos-tratamientos-para-el-parkinson#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thesmartcityjournal.com\/es"},{"@type":"ListItem","position":2,"name":"La industria farmac\u00e9utica investiga casi un centenar de nuevos tratamientos para el Parkinson"}]},{"@type":"WebSite","@id":"https:\/\/www.thesmartcityjournal.com\/es\/#website","url":"https:\/\/www.thesmartcityjournal.com\/es\/","name":"thesmartcityjournal.com","description":"","publisher":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thesmartcityjournal.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.thesmartcityjournal.com\/es\/#organization","name":"thesmartcityjournal.com","url":"https:\/\/www.thesmartcityjournal.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.thesmartcityjournal.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2026\/09\/logo-smart-city-journal-1.png","contentUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2026\/09\/logo-smart-city-journal-1.png","width":346,"height":91,"caption":"thesmartcityjournal.com"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thesmartcityjournal","https:\/\/x.com\/SmartCityJour_","https:\/\/www.instagram.com\/thesmartcityjournal_\/","https:\/\/www.tiktok.com\/@thesmartcityjournal","https:\/\/www.linkedin.com\/company\/the-smart-city-journal\/","https:\/\/www.youtube.com\/channel\/UCIPTMzK206pVFxMNjO7SSxw"]},{"@type":"Organization","@id":"https:\/\/www.thesmartcityjournal.com\/es\/#\/schema\/person\/39c9da1aeac1b5c2d179ef9e4e293cf4","name":"Redacci\u00f3n de The Smart City Journal","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"Redacci\u00f3n de The Smart City Journal"},"description":"Equipo de redacci\u00f3n de The Smart City Journal.","url":"https:\/\/www.thesmartcityjournal.com\/es\/author\/smart-city"},{"@type":["Organization","NewsMediaOrganization"],"@id":"https:\/\/www.thesmartcityjournal.com\/es#organization"},{"@type":"SiteNavigationElement","@id":"https:\/\/www.thesmartcityjournal.com\/es#site-navigation","cssSelector":[".cib-main-menu"]},{"@type":"WPHeader","@id":"https:\/\/www.thesmartcityjournal.com\/es#header","cssSelector":[".cib-header"]},{"@type":"WPFooter","@id":"https:\/\/www.thesmartcityjournal.com\/es#footer","cssSelector":[".cib-footer"]}]}},"_links":{"self":[{"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/posts\/14831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/comments?post=14831"}],"version-history":[{"count":0,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/posts\/14831\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/media\/14830"}],"wp:attachment":[{"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/media?parent=14831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/categories?post=14831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/tags?post=14831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}